ABT
Abbott LaboratoriesStockHealthcare$88.41−$0.09 (-0.10%)as of Jun 18, 4:00 PM ET
Key stats
- Market cap
- 154B
- P/E (ttm)
- 24.5×
- Fwd P/E
- 14.6×
- P/S
- 3.4×
- P/B
- 3.0×
- EPS (ttm)
- $3.57
- EV/EBITDA
- 18.6×
- EV/Sales
- 3.9×
- P/FCF
- 20.9×
- FCF yield
- 4.79%
- Net margin
- 13.91%
- ROE
- 12.06%
- ROA
- 5.68%
- Debt / equity
- 0.57×
- Current ratio
- 1.39
- Beta
- 0.62
- Div yield
- 2.85%
- 52W high
- -36.42%
- Rel volume
- 3.15×
- 30D $ vol
- 1.2B
Performance
1D
-0.10%
1W
-1.38%
1M
-0.46%
3M
-17.52%
YTD
-28.81%
1Y
-33.16%
5Y
-19.56%
Financial statements
Open full ABT financials →Related Healthcare
1MAbbott Laboratories (ABT) trades at $88.41 with a live price and an interactive chart covering 23+ years of daily price history, plus key valuation metrics. ChartRow also publishes ABT's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full ABT financial statements →
